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We derived adult neural stem/progenitor cells (NSPCs) from the sub-ventricular zone
of male and female mice to examine direct responses to principal sex hormones. In
the presence of epidermal growth factor (EGF) and fibroblast growth factor-2 (FGF2)
NSPCs of both sexes expressed nestin and sox2, and could be maintained as
neurospheres without addition of any sex hormones. The reverse was not observed;
neither testosterone (T), 17β-estradiol (E2) nor progesterone (P4) was able to support
neurosphere growth in the absence of EGF and FGF2. Ten nanomolar T, E2 or P4
induced nestin(+) cell proliferation within 20 min and enhanced neurosphere growth over
7 days irrespective of sex, which was abolished by Erk inhibition with 20 µM U0126.
Maintaining neurospheres with each sex hormone did not affect subsequent neuronal
differentiation. However, 10 nM T, E2 or P4 added during differentiation increased βIII
tubulin(+) neuron production with E2 being more potent compared to T and P4 in
both sexes. Androgen receptor (AR) inhibition with 20 µM flutamide but not aromatase
inhibition with 10 µM letrozole reduced basal and T-induced neurosphere growth in
females, while only concurrent inhibition of AR and aromatase produced the same effect
in males. This sex-specific effect was supported by higher aromatase expression in male
neurospheres compared to females measured by Western blot and green fluorescent
protein (GFP) reporter. Ten micromolar menadione induced oxidative stress, impaired
neurosphere growth and up-regulated aromatase expression in both sexes. However,
under oxidative stress letrozole significantly exacerbated impaired neurosphere growth in
males only. While both E2 and T could prevent oxidative stress-induced growth reduction
in both sexes, the effects of T were dependent on innate aromatase activity. We show for
the first time that intrinsic androgen and estrogen signaling may impact the capacity of
NSPCs to produce neural progenitors under pathological conditions of oxidative stress.
Keywords: neurosphere, sex hormones, aromatase, oxidative stress, neural stem cell, proliferation, estradiol,
testosterone
Introduction
The central edict that adult mammalian brains do not produce new neurons persevered up
until relatively recently. The eventual acceptance that neural stem/progenitor cells (NSPCs)
do exist in adult mammalian brains was a watershed in our view of the brain’s regenerative
capacity (Gross, 2000; Ransome, 2012b; Faigle and Song, 2013). Adult NSPCs are largely thought
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to be anatomically restricted; the sub ventricular zone (SVZ) of
the lateral ventricles is one major site where NSPCs continue
to produce new neurons (Gould, 2007; Ming and Song, 2011).
Under otherwise normal physiology, SVZ NSPCs give rise to
new neurons in the process of neurogenesis that populate the
olfactory bulb (Ming and Song, 2011). However, pathological
conditions such as traumatic brain injury and stroke, appear
capable of driving SVZ NSPCs into populating injured cortex
with new neurons (Sawada and Sawamoto, 2013). Variably
this process has been coined injury-induced neurogenesis and
generated significant interest in understanding factors that
regulate adult NSPC properties.
The innate efficacy of injury-induced neurogenesis is limited
by the apparent failure of NSPCs to produce persistent neurons
in the injured region. At present this failure means adult
NPSCs represent a potential endogenous repair mechanism yet
to be harnessed. The objective of therapeutically exploiting
this potential underscores intense efforts to understand the
mechanisms that govern NSPC regulation. A significant step
toward understanding cell-intrinsic regulation was achieved
when NSPCs were isolated from adult SVZ and propagated in
vitro (Reynolds and Weiss, 1992). Cultured adult NSPCs derived
from the SVZ can be propagated as floating cell aggregates
termed neurospheres, within which the key self-renewal and
multipotent NSPC properties are maintained. The neurosphere
assay has proven to be a powerful tool in examining molecular
control of these key NSPC properties with the aim of promoting
the endogenous capacity of the injured brain to self-repair
(Bellenchi et al., 2013).
Successful therapeutic targeting of adult NSPCs requires
fundamental gaps in our current knowledge to be addressed
(Ming and Song, 2011). One key focus is on the potential
sexually-dimorphic regulation of adult NSPCs. The primary
sex hormones 17β-estradiol (E2) and testosterone (T) were
amongst the first physiological factors observed to influence
adult NSPCs (Tanapat et al., 1999; Galea, 2008; Ransome,
2012b). Disparity in gonad-derived sex hormone levels is a
principal determinant of sexual differentiation (Arnold, 2009)
and therefore circulating E2 and T could be prime mediators
of sexually-dimorphic NSPC regulation. However, a stable
framework describing sex-specific adult NSPC responses to
sex hormones remains elusive (Lagace et al., 2007; Tatar
et al., 2013). Genes encoding key enzymes involved in
sex hormone synthesis are expressed in the adult brain
(Mensah-Nyagan et al., 1999), which provides the capacity
to metabolize circulating sex hormones that freely enter
the central nervous system. This capacity confounds the
ability to attribute changing circulating sex hormone levels
with functional changes in NSPCs. A prime example is the
localized brain expression of the Cyp19 gene encoding the
aromatase enzyme responsible for E2 synthesis (Boon et al.,
2010; Stani´c et al., 2014). Aromatase synthesizes E2 using
T as a direct precursor; hence cells expressing aromatase
can convert circulating T directly into E2, thereby activating
androgen receptors (AR) or estrogen receptors (ER), respectively.
Limited reports using adult neurospheres to examine direct
cell effects suggest NSPCs express AR and ER and therefore
in principal can be influenced directly by sex hormones
(Brännvall et al., 2005; Ray et al., 2008; Waldron et al.,
2010a,b). In this study we isolated NSPCs from both female
and male adult mice to examine if cell-direct effects of sex
hormones at equal molar concentrations were determined by
genetic sex.
Materials and Methods
Animals
All experimental procedures performed in this study conformed
to the Australian National Health and Medical Research Council
published code of practice, and were approved by the Animal
Ethics Committee of The Florey Institute of Neuroscience
and Mental Health (#12-086). C57Bl6 male and female mice
8–10 weeks of age were purchased from the Animal Resources
Centre (Canning Vale, WA, and Australia) and allowed to
acclimatize for 1 week in the bio-resource animal facility at the
Florey Institute for Neuroscience and Mental Health (FINMH)
before being used to derive adult neural stem progenitor
cells. Male and female mice from the transgenic CYP19A1-
EGFP BAC-mouse strain (FVB/N) were obtained at 8–10
weeks of age from stocks maintained within the FINMH bio-
resource animal facility and described previously (Stani´c et al.,
2014).
Neurosphere Culture
NSPCs were isolated from the SVZ of 8–10 week old mice
as described (Scott et al., 2006) and cultured in neurosphere
proliferation media consisting of Advanced Dulbecco’s Modified
Eagle’s Medium (DMEM):F12 (Invitrogen, Life Technologies,
Mulgrave, VIC, Australia) supplemented with 100 U/ml
penicillin/streptomycin, 0.25 µg/ml Funlzone® (Antibiotic-
Antimycotic, Gibco), 20 ng/ml epidermal growth factor (EGF;
Peprotec, NJ, USA), 10 ng/ml fibroblast growth factor 2 (FGF2;
Peprotec), 0.1 mg/ml apo-transferrin (Sigma-Aldrich, Castle
Hill, NSW, Australia), 5 µg/ml insulin, 100 µM putrescene
(Sigma-Aldrich), 30 nM sodium selenite (Sigma-Aldrich),
2 mM GlutaMax™ (Invitrogen). Primary neurospheres were
then maintained by weekly passaging through dissociating in
TrypLE™ (Gibco) with 200 U/ml DNase I (Roche Products
Pty Ltd, NSW, Australia). Viable cells were counted using a
hemocytometer and trypan blue dye exclusion and seeded at
50,000 cells/ml in proliferation media in either T75 cm2 or
T25 cm2 Nunc flasks (Thermo Scientific, MA, USA) and kept
humidified at 37◦C with 5% CO2. Each line was maintained for
experimentation until passage 10.
Neurosphere Growth Assay/Proliferation Assay
NSPCs were seeded at 20,000 cells/ml of proliferation media
in 12 well culture plates (1.5 ml per well) and maintained
± treatments for times indicated. Neurospheres were then
dissociated in TrypLE/DNase I and viable cells counted using
a hemocytometer and trypan blue dye exclusion and the
percentage increase in cells determined. Results derived from
three independent male and three independent female cell
lines are expressed as mean ± SEM. For acute experiments
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NSPCs were seeded at 50,000 cells/ml of proliferation media
in T25 cm2 flasks and grown for 4 days then collected by
centrifugation and resuspended in 8 ml of proliferation media.
Aliquots (500 µl) were then added to 8-well chamber slides
(Millipore, Bayswater, VIC, Australia) coated with 50 ng/ml
poly-D-lysine (Sigma-Aldrich) and 20 ng/ml mouse laminin
(Invitrogen) for 30 min before addition of treatments for 20
min. Cells were then washed in ice-cold 0.1 M phosphate
buffered saline (PBS) then fixed in 4% paraformaldehyde
(PFA) on ice for 20 min. Immunocytochemistry was then
performed; cells were blocked in 0.1 M PBS containing
5% normal donkey serum (Millipore) and 0.1% triton-X100
(Sigma-Aldrich) for 60 min at 20◦C then incubated with
primary antibodies, rabbit anti-Ki67 (1:300, DKSH Australia
Pty Ltd., VIC, Australia), mouse anti-nestin (1:300, R and
D Systems, MN, USA) for 3 h, washed in PBS then
incubated in secondary antibodies, Alexa fluor 488-conjugated
donkey anti-rabbit (1:400, Molecular Probes, Life Technologies)
and Alexa fluor 555-conjugated donkey anti-mouse (1:400,
Molecular Probes) then counterstained with 4′,6-Diamidino-2-
Phenylindole (1:2000, DAPI, Sigma-Aldrich) for 10 min and
coverslipped in Fluoromount (DAKO, North Sydney, NSW,
Australia). Digital images were taken using an Olympus BX61
microscope with an UPlan FL N 20 × objective lens (Olympus,
Notting Hill, VIC, Australia) in 15 randomly chosen areas
per chamber well per condition and coded. Coded images
were then imported into Image J software (NIH, Bethesda,
MD, USA) and randomly chosen neurospheres were analyzed
if they were a clearly demarcated mono layer, containing
25–40 DAPI/nestin(+). Results are expressed as percentage
nestin/DAPI(+) cells co-labeled with Ki67, mean ± SEM from
three independent female and three independent male cell lines.
Immunocytochemical assessment of adult NSPC markers was
also performed as described above using mouse anti-nestin
and goat anti-SOX2 (both 1:300, R and D Systems) followed
by Alexa fluor 555-conjugated donkey anti-goat, Alexa fluor
488-conjugated donkey anti-mouse and DAPI. Between 40–50
neurospheres per condition were assessed for nestin/sox2/DAPI
co-labeling.
Neurosphere Growth/Proliferation Assay
Treatments
Pilot proliferation assays showed no change in neurosphere
growth when 0.01% v/v ethanol or dimethyl sulfoxide
(DMSO, Sigma-Aldrich) were added to the media compared
to proliferation media alone. T, E2 and P4 were obtained
from Sigma-Aldrich and 1 mM stock solutions made in 100%
ethanol. For each assay 1 mM stock solutions were serially
diluted in media to a final concentration of 10 nM (except
where indicated in results) with a final ethanol concentration of
0.001%. Flutamide and letrozole (Sigma-Aldrich) were made to
10 mM stock solutions in 100% ethanol and DMSO, respectively
and serially diluted in media to a final concentration of 10
and 20 µM, respectively. Ten millimolar Menadione (Sigma-
Aldrich) stock solutions in 100% ethanol were made regularly
and protected from light before serial dilution in media to a final
concentration of 10µM. The Erk inhibitor U0126 (Cell Signaling
Technologies Inc., MA, USA) was used at a final concentration
of 20 µM.
Neurosphere Neuronal Differentiation Assay
Dissociated neurospheres were seeded at 50,000 cells/ml in 6 ml
proliferation media ± treatments in T25 cm2 flasks and grown
for 4 days. Neurospheres were then collected by centrifugation
and resuspended in 4 ml of fresh proliferation media then
aliquoted into poly-D-lysine/laminin coated 8-well chamber
slides (Millipore) 500 µl/chamber. After 6 h proliferation
media was replaced with differentiation media consisting of
DMEM:F12 supplemented with 2 mMGlutamax, 1% Antibiotic-
Antimycotic (all Gibco), 10 µM retinoic acid (Sigma-Aldrich),
0.1 mg/ml apo-transferrin (Sigma-Aldrich) and 5 µg/ml insulin,
± treatments as indicated. After 2 days cultures were washed
with ice-cold PBS then fixed on ice with 4% PFA for 20 min.
Immunocytochemistry was then performed; cells were blocked
in 0.1 M PBS containing 5% normal donkey serum (Millipore)
and 0.1% triton-X100 (Sigma-Aldrich) for 60 min at 20◦C
then incubated with mouse anti-βIII tubulin (1:1000, Promega
Corp., WI, USA) for 3 h, washed in PBS then incubated in
Alexa fluor 555-conjugated donkey anti-mouse (1:400,Molecular
Probes), then counterstained with DAPI (1:2000, Sigma-Aldrich)
for 10 min and coverslipped in Fluoromount (DAKO). Digital
images were taken using an Olympus BX61 microscope with
an UPlan FL N 20 × objective lens (Olympus) in 15 randomly
chosen areas per chamber well per condition and coded. Image
J software (Bethesda, MD, USA) was used to count and the
number of βIII-tubulin(+) cells as a proportion of total DAPI(+)
cells per image. Results are expressed as mean ± SEM from
three independent female and three independent male cell
lines.
Western Blot Analyses
Control neurospheres and those treated with 10 µMmenadione
for 3 h were collected by centrifugation and lysed on ice
for 30 min in standard lysis buffer with added protease
inhibitor cocktail (Sigma) before being cleared by centrifugation
to generate whole-cell lysates. Protein concentration was
determined by the Card Direct™method (Millipore) and 30
µg of protein per sample were resolved under reducing
conditions on 8–16% polyacrylaminde gels for 1 h at 90V
then transferred to an Immobilon PVDF-FL membrane
(Millipore) for 3 h at 200 mA. After being washed in 0.1
M tris-buffered saline (TBS) membranes were blocked
with 5% skim milk powder in TBS for 1 h at 20◦C then
incubated in rabbit anti-aromatase (1:500, Sigma Aldrich)
or rabbit anti-AR (N20, 1:500, Santa Cruz Biotechnology,
Inc., TX, USA) diluted in TBS overnight at 4◦C. Membranes
were washed again then incubated in donkey anti-rabbit
IRDye680 (1:5000, Li-Cor, Lincoln, NE, USA) for 3 h at
20◦C. Digital images of immunoreactive bands were captured
using an Odyssey Classic near infrared detection system.
Membranes were then re-probed with mouse anti-βactin
(1:5000, Sigma) then donkey anti-mouse IRDye800 (1:5000,
Li-Cor) and digital images captured. Gray-scale digital images
were subject to densitometry using Image J software (NIH,
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Bethesda, MD, USA). Optical densities of aromatase and AR
immunoreactive bands were measured and normalized to
respective βactin bands. Results are expressed as mean ± SEM
from three independent female and three independent male cell
lines.
Statistical Analysis
All statistical analyses were performed using GraphPad Prism
5.0 software (GraphPad Software, Inc., San Diego, CA,
USA). Student’s un-paired 2-tailed t-test and multiple group
comparisons using one and two way ANOVA were used with
a Tukey’s multiple comparison test for ANOVA. In all cases,
significance was set at P < 0.05.
Results
Direct Androgen Signaling in NSPCs
To clarify whether T could directly affect NSPCs, we analyzed AR
protein levels in female and male neurospheres by quantitative
Western blot (Figure 1A). AR protein was found in neurospheres
of both sexes with densitometry analyses and statistical t-test
showing no significant differences in levels between sexes
(Figure 1B). Based on previous work showing effects of
T derivatives on adult female neurospheres (Brännvall et al.,
2005), we next examined different doses of exogenous T (1 nM,
10 nM or 50 nM) on female neurospheres over 7 days and
compared changes in growth (Figure 1C). One-way ANOVA
analyses showed a significant main effect of treatment, F(3,8) =
7.81, p < 0.01, with Tukey’s multiple comparisons test showing
significant increases induced by 10 nM T compared to control,
∗p < 0.05, and 10 nM T compared to 1 nM T, ∗∗p < 0.01.
Based on these data we proceeded to compare the equal molar
FIGURE 1 | After 7 days under control conditions, total cell protein was
obtained from female and male neurospheres then resolved by sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and
probed for androgen receptor (AR) and β actin (A). Quantitative
densitometry analyses demonstrate similar protein levels of androgen receptor
in both female and male neurospheres (B). Female neurospheres were grown
over 7 days ± 1 nM, 10 nM or 50 nM testosterone (T) then dissociated into
single cells and counted (C). While 1 nM T had no effect, both 10 and 50 nM T
significantly increased neurosphere growth. Results show mean ± SEM, ∗p <
0.05, ∗∗p < 0.01, one-way ANOVA with Tukey’s multiple comparison test.
effects of T, P4 and E2 on male and female NSPCs using a final
concentration of 10 nM.
Sex Hormone Effects on Neural Stem Cell
Markers, Neurogenic Potential and Neurosphere
Maintenance
Our present study maintained neurospheres in the presence of
potent mitogens EGF and FGF2 but without P4. Because P4 is
a widely used standard component of neurosphere media, we
first examined whether the absence of P4 affected expression of
established markers of adult NSPCs, nestin and sox2 (Doetsch
et al., 1999; Faigle and Song, 2013). Neurospheres grown for
4 days at passages 2 and 10 maintained ± 10 nM of T or P4
or E2 were allowed to adhere to a laminin substrate for 1 h
before fixation. Subsequent immunocytochemistry showed all
cells (DAPI+ nuclei) expressed both nestin and sox2 irrespective
of sex or which sex hormone they were maintained in for up to
10 passages (Figure 2A). We next tested whether equal molar
concentrations of T, E2 or P4 could independently maintain
neurosphere growth without EGF and FGF2. Neurospheres
grown over 7 days in standard proliferation media containing
EGF and FGF were passaged into media with either 10 nM
T, E2 or P4 without EGF or FGF where we observed an overt
paucity in neurosphere formation over a subsequent 7 days
(Figure 2B). However, neurosphere growth resumed following
re-passaging into standard proliferation media containing EGF
and FGF (Figure 2B).
Next we maintained male and female neurospheres over five
serial passages ± 10 nM T, E2 or P4. On the 6th passage we
maintained neurospheres from all treatments in media without
sex hormones for 4 days. These neurospheres were then allowed
to adhere to a laminin substrate and differentiated without sex
hormones for 2 days then assessed for neuronal differentiation
using βIII tubulin immunocytochemistry (Figure 2C). One-way
ANOVA comparison of neuronal differentiation showed no
change between neurospheres maintained without sex hormones
or with either T, P4 or E2 in females (Figure 2D), F(3,8) =
0.3803, p = 0.7700, and males, F(3,8) = 0.2932, p = 0.8293
(Figure 2E).
Sex Hormone Effects on NSPC Proliferation and
Neuronal Differentiation
We adopted an immunocytochemical approach utilizing
the intrinsic cell proliferation marker Ki67 to assess acute
proliferative effects on nestin(+) NSPCs (Figure 3A).
Neurospheres grown for 4 days in standard proliferation
media were allowed to adhere to a laminin substrate for 60 min
and then treated with 10 nM of either T, E2 or P4 for 20 min
then fixed for immunocytochemistry. Neurospheres typically
flattened and separated but remained within a defined margin.
We randomly sampled adherent neurospheres addressing
possible bias of size by restricting analyses to neurospheres
containing 15–25 DAPI/nestin (+) cells. In female cultures
one-way ANOVA showed a statistically significant main
effect of treatment on the percentage of DAPI/nestin(+) cells
expressing Ki67 per neurosphere, F(3,8) = 20.15, p < 0.001
(Figure 3B). Tukey’s multiple comparison test showed that T,
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FIGURE 2 | Female and male neural stem/progenitor cells (NSPCs)
were maintained as neurospheres for 10 passages without sex
hormones or with either 10 nM of; testosterone (T), 17βestradiol (E2) or
progesterone (P4). At passages 2 and 10 neurospheres grown for 4 days
from each group were allowed to adhere to a laminin substrate for 60 min,
fixed and immunostained for neural stem cell markers nestin and sox2
(A, neurospheres maintained without any sex hormones at passage 2 shown).
Female and male neurospheres grown for 1 passage with epidermal growth
factor (EGF) and fibroblast growth factor-2 (FGF-2) with either 10 nM T, E2 or
P4 (sex hormones) then passaged into media with the same sex hormone but
without EGF or FGF showed a paucity in neurosphere formation, but
re-addition of EGF and FGF stimulated neurosphere growth again (B, phase
image of male and female neurospheres with T shown). Female and male
neurospheres were maintained for five serial passages without sex hormones
or with 10 nM T, E2 or P4 were then allowed to differentiate without any
(Continued)
FIGURE 2 | Continued
sex hormones for 72 h when βIII-tubulin (red) immunocytochemistry was used
to detect neuronal differentiation (C, neurons maintained without any sex
hormones shown). No effect of maintenance in any condition was seen on the
proportion of neuronal differentiation in female (D) or males (E). Results show
mean ±SEM. Scale bar = 50 µM (A,C) 150 µM (B).
E2 and P4 independently increased proliferation compared to
control, ∗∗p < 0.01, ∗∗∗p < 0.005, (Figure 3B), but showed no
significant differences between T, E2 or P4. The same analyses
in male neurospheres demonstrated similar results with one-
way ANOVA showing a statistically significant main effect of
treatment on the percentage of DAPI/nestin(+) cells expressing
Ki67 per neurosphere, F(3,8) = 16.59, p < 0.001 (Figure 3C).
Again Tukey’s multiple comparison test showed that T, E2 or
P4 independently increased proliferation compared to control
in males but showed no change between each hormone, ∗∗p <
0.01, (Figure 3C). Female and male neurospheres maintained
without sex hormones in standard proliferation media were
allowed to adhere to a laminin substrate and differentiate for 2
days in differentiation media ± 10 nM T, E2 or P4 whereupon
βIII tubulin immunocytochemistry was used to assess neuronal
differentiation (Figure 3D). One-way ANOVA showed a
significant main effect of treatment in female neurospheres,
F(3,8) = 45.59, p < 0.0001 and Tukey’s multiple comparisons test
showed that compared to control: T, ∗p< 0.05; P4, ∗p< 0.05 and
E2, ∗∗p < 0.01 all increased neuronal differentiation, while E2
also showed a significant effect compared to T and P4, both #p
< 0.001 (Figure 3E). An almost exact pattern was found when
we performed one-way ANOVA on male neurosphere data; a
significant main effect of treatment, F(3,8) = 40.58, p < 0.0001
and Tukey’s multiple comparisons test showed that compared
to control: T, ∗p < 0.05; P4, ∗p < 0.05 and E2, ∗∗p < 0.001
all increase neuronal differentiation, while E2 also showed
a significant effect compared to T and P4, both #p < 0.001,
(Figure 3F).
Sex Hormone Effects on Neurosphere Growth
We next examined whether the acutely induced proliferation
described in Figures 3A,B enhanced neurosphere growth by
measuring the percentage increase in NSPCs after 7 days ±
10 nM T, E2 or P4 (Figures 4A,B). One-way ANOVA of
female cultures showed a significant main effect of treatment
on percentage increase in NPSCs, F(3,8) = 8.46, p < 0.001,
(Figure 4A). Tukey’s multiple comparison test showed that T, E2
and P4 independently increased neurosphere growth compared
to control, ∗p < 0.05, ∗∗p < 0.01, without any significant
difference between each of the sex hormones (Figure 4A). In
male cultures one-way ANOVA showed the same pattern with
a significant main effect of treatment on percentage increase in
NPSCs, F(3,8) = 10.95, p< 0.01 and Tukey’s multiple comparison
test showing T, E2 and P4 independently increased neurosphere
growth compared to control, ∗p < 0.05, ∗∗p < 0.01, without any
significant difference between each sex hormone, (Figure 4B).
The acute proliferative effects of T, E2 or P4 on NSPCs also
prompted us to consider the involvement of rapid, non-classical
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FIGURE 3 | Female and male NSPCs were grown as neurospheres
without sex hormones for 4 days then allowed to adhere to a laminin
substrate and expose to either 10 nM testosterone (T), 17β-estradiol
(E2), progesterone (P4) for 20 min before Ki67/nestin double label
fluorescent immunocytochemistry was performed (A, female control
neurosphere shown). The proportion of DAPI/nestin-labeled cells expressing
Ki67 per neurosphere was increased by 20 min of either T, E2 or P4 compared
to controls in both females (B) and males (C). Female and male neurospheres
maintained without sex hormones were differentiated on a laminin substrate
for 72 h ± 10 nM T, E2 or P4 when βIII-tubulin (red) immunocytochemistry
(D) showed that while T, P4 and E2 increased the proportion of neuronal
differentiation compared to controls, E2 was more potent compared to T and
P4 in females (E) and males (F). Results show mean ± SEM, ∗p < 0.05, ∗∗p <
0.01, ∗∗∗p < 0.005 compared to control, #p < 0.05 compared to T and P4,
one-way ANOVA with Tukey’s multiple comparisons test. Scale bar = 50 µM.
steroid signaling. Several well characterized rapid signal-
transduction pathways have been implicated in sex hormone
actions, including extracellular-regulated kinase pathways such
as MEK1-Erk, which also play regulatory functions in NSPCs
(Simoncini and Genazzani, 2003; Faigle and Song, 2013). The
protein kinase inhibitor U0126 can inhibit MEK1-stimulated Erk
phosphorylation at 10 µM and has been used up to 30 µM to
examine neurosphere properties, including inhibition of FGF2-
stimulated Erk phosphorylation (Davies et al., 2000; Jin et al.,
2005; Bain et al., 2007; Dottori et al., 2008). We tested the
ability of T, E2 or P4 at equal molar concentrations to induce
neurosphere growth over 7 days with concomitant MEK1-Erk
signaling inhibition using 20 µM U0126. In female cultures
one-way ANOVA showed a significant main effect, F(4,10) =
3.72, p < 0.05, with Tukey’s multiple comparisons test showing
FIGURE 4 | Female and male neurospheres were grown for 7 days ±
10 nM of either testosterone (T), 17β-estradiol (E2), progesterone (P4).
Each sex hormone significantly increased neurosphere growth to the same
degree compared to controls in females (A) and males (B) Over a 7 day
period the Erk inhibitor U0126 significantly impaired neurosphere growth
compared to controls and abolished the increase in response to each sex
hormone in females (C) and males (D). Results show mean ± SEM, ∗∗p <
0.05, ∗∗p < 0.01 compared to controls, one-way ANOVA with Tukey’s multiple
comparisons test.
that neurosphere growth was significantly attenuated by 20 µM
U0126 compared to controls, ∗p < 0.05, (Figure 4C). Once
again the pattern of statistical analyses results were the same
in male cultures; one-way ANOVA showed a significant main
effect, F(4,10) = 4.73, p< 0.05, with Tukey’s multiple comparisons
test showing significantly attenuated of neurosphere growth by
20 µM U0126 compared to controls, ∗p < 0.05, (Figure 4D).
Comparisons of U0126 + sex hormones to either controls
or U0126 alone showed no statistically significant changes in
either sexes indicating U0126 impaired the capacity of each sex
hormone to induce neurosphere growth, (Figures 4C,D).
Differentiating Between Androgen and Estrogen
Effects on Neurosphere Growth
Aromatase is an enzyme catalyzing the conversion of T
into E2 and one report has shown aromatase expression in
adult rat-derived neurospheres (Boon et al., 2010; Waldron
et al., 2010b). The implication for cells expressing aromatase
is that exogenous T, through metabolism into E2, could act
through ER, in addition to its cognate AR. We used a
pharmacological approach to examine whether exogenous T
promotes neurosphere growth through estrogenic or androgenic
pathways, employing the specific aromatase inhibitor letrozol
and AR antagonist flutamide. These compounds have high
specificity, and used in human cancer cell lines show for example,
decreased E2 synthesis and anti-proliferative effects of letrozole
at concentrations ranging from 10 nM to 100 µM (Bhatnagar
et al., 1990; Brogden and Chrisp, 1991; Mitropoulou et al.,
2003; Han et al., 2008). We examined female neurosphere
growth in the presence of letrozole and flutamide alone or
combined and ± 10 nM T, with one-way ANOVA showing
a significant main effect of treatment, F(6,14) = 39.83, p <
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FIGURE 5 | Female and male neurospheres were grown for 7 days ±
10 µM of the aromatase inhibitor letrozole, 10 µM of the androgen
receptor antagonist flutamide ± 10 nM testosterone (T) as indicated.
Letrozole alone did not affect female of male neurosphere growth.
Flutamide alone or with letrozole impaired female neurosphere growth
(A), while in males only the combined addition of letrozole and flutamide
reduced growth (B). Co-addition of T induced female neurosphere growth
in the presence of letrozole but not flutamide or letrozole/flutamide
combined (A) and in males only combined letrozole/flutamide significantly
reduced growth compared to either inhibitor alone. Results show mean ±
SEM, ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.005, ∗∗∗∗p < 0.001, one-way ANOVA
with Tukey’s multiple comparisons test.
0.001 (Figure 5A). Tukey’s multiple comparison test showed
that compared to control neurosphere growth, addition of
letrozole alone had no effect, while flutamide with or without
letrozole significantly inhibited growth, ∗p < 0.05, (Figure 5A).
When 10 nM T was added with letrozole, neurosphere growth
was increased significantly compared to all other groups,
∗∗∗∗p < 0.001, while 10 nM T applied with flutamide alone or
flutamide and letrozole did not stimulate growth (Figure 5A).
In male neurospheres, we observed a different pattern of
results. One-way ANOVA demonstrated a significant main
effect of treatment, F(6,14) = 13.08, p < 0.001 (Figure 5B).
However, contrasting the effects on female neurosphere growth
Tukey’s multiple comparison test showed that compared to
controls 10 nM T increased growth in the presence of
flutamide, ∗p< 0.05, but not letrozole (Figure 5B). Additionally,
neurosphere growth when 10 nM T was applied in the presence
of both letrozole and flutamide was significantly reduced
compared to either inhibitor alone + 10nM T, ∗∗∗p < 0.005
(letrozole alone), ∗∗∗∗p < 0.001 (flutamide alone) (Figure 5B).
Oxidative Stress, Neurosphere Growth and
Aromatase Expression
Local aromatase-mediated E2 synthesis is thought to be induced
by brain insults through mechanisms such as oxidative stress
(Garcia-Segura et al., 2003; Cornelius et al., 2013). This,
together with Figure 5 data showing sex-specific effects of
letrozole, prompted us to examine aromatase expression in
adult NSPCs. Firstly, we used a commercial fluorescent marker
of reactive oxygen species (ROS) to demonstrate that 10 µM
menadione—a compound widely used to model oxidative stress
in vitro (Morrison et al., 2011)—induced ROS in cultured
neurospheres (Le Belle et al., 2011; Figure 6A). Next we
derived neurospheres from adult male and female transgenic
mice that express a green fluorescent protein (GFP)—Cyp19
construct (Stani´c et al., 2014). These mice express GFP under
the same physiological promoter control as the Cyp19 gene
that encodes aromatase, such that GFP is a reliable reporter
of aromatase expression. Male and female GFP-aromatase
neurospheres grown for 5 days were imaged with live-cell
phase and fluorescent microscopy then after a further day
challenged for 24 h with 10 µMmenadione to induce formation
of ROS (Loor et al., 2010) and imaged again (Figure 6B).
Randomly examining 40–50 imaged neurospheres per condition
appeared to qualitatively demonstrate higher basal levels of
GFP fluorescence in males compared to females indicating
higher aromatase expression. Furthermore, menadione appeared
to induce GFP fluorescence in neurospheres of both sexes
(Figure 6B). To substantiate this qualitative observation, we next
isolated total cell protein from female and male neurospheres
for quantitative Western blot. Whole cell lysates were derived
from control neurospheres and those challenged with 10 µM
menadione for 3 h and proteins resolved by SDS-PAGE and
probed with an aromatase antibody that detected a band at
approximately 55 kilo-Daltons the expected molecular weight
(Figure 6C). Subsequent densitometry analyses using two-way
ANOVA showed a significant interaction between sex and
treatment, F(1,8) = 24.28, p < 0.001 and a significant main effect
of treatment, F(1,8) = 133.4, p < 0.0001 (Figure 6C). Multiple
comparisons Tukey’s tests showed under control conditions
male neurospheres had higher aromatase levels compared to
females, ∗p < 0.01 and that menadione-induced oxidative stress
increased aromatase expression in females, ∗∗p < 0.001 control
vs. menadione and males, ∗p < 0.01 control vs. menadione
(Figure 6C).
We next tested how oxidative stress effected neurosphere
growth over 7 days. Neurospheres of both sexes grown with
10 µM menadione showed comparative smaller sizes by 5 days
(Figure 7A). We also immunostained adherent female and male
neurospheres after 5 days ± 10 µM menadione to show an
overt impairment in nestin(+) morphology (Figure 7B). We
then assessed female and male neurosphere growth over 7 days
± 10 µM menadione alone or in combination with 10 µM
letrozole or 10 nME2 (Figures 7C,D). One-way ANOVA showed
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FIGURE 6 | Five micromolar CellROX orange™ was used with live-cell
imaging to fluorescently detect basal and menadione-induced levels
of ROS in female and male neurospheres (A, panels show example of
female neurospheres incubated ±10 µM menadione for 48 h).
Neurospheres derived from GFP-aromatase transgenic mice were grown for 5
days under control conditions then briefly imaged by both light microscopy
and epi-fluorescence (control) then after another day challenged with 10 µM
menadione for 48 h and imaged again qualitatively showing higher basal
aromatase expression in males compared to females and also
menadione-induced aromatase expression in both sexes (B). Total cell protein
was isolated from male and female neurospheres grown ± 10 µM menadione
for 5 h [C = control (con), M = menadione (men)] and resolved by SDS-PAGE
and probed for aromatase and β actin (C). Quantitative densitometry analyses
showed significantly higher levels of aromatase in male compared to female
neurospheres under controls conditions and a significant increase in
aromatase expression in both sexes after menadione treatment (C). Results in
C show mean ± SEM, ∗p < 0.01, ∗∗p < 0.001, two-way ANOVA with Tukey’s
multiple comparisons test.
a significant main effect of treatment in female neurospheres,
F(3,8) = 10.33, p < 0.005, with Tukey’s multiple comparison test
showing that menadione alone, ∗p < 0.05 and menadione +
letrozole, ∗∗p < 0.01 decreased neurosphere growth compared
to control, while a significant difference in neurosphere growth
between menadione + letrozole and menadione + E2 was
also evident, ∗p < 0.05 (Figure 7C). One-way ANOVA of
male neurosphere data also showed a significant main effect
of treatment, F(3,8) = 50.46, p < 0.001 (Figure 7D). Tukey’s
multiple comparison test in males showed a similar pattern to
females, however in males the combination of menadione +
letrozole significantly decreased neurosphere growth compared
to menadione alone, ∗∗p < 0.01 (Figure 7D). Of important note
E2 was able to rescue the menadione-inhibition of growth in both
female and male neurospheres (Figures 7C,D).
We next assessed whether T could also rescue menadione-
induced inhibition of female and male neurosphere growth
(Figures 7E,F). One-way ANOVA of female neurosphere growth
showed a significant main effect of treatment, F(4,10) = 8.28, p <
0.005 (Figure 7E). Tukey’s multiple comparisons test replicated
our previous data set showing menadione-induced inhibition of
growth compared to controls, ∗p < 0.05, while 10 nM T added
with menadione abolished this deficit (Figure 7E). However,
when T was added to menadione-treated cultures with letrozole
or flutamide then neurosphere growth remained diminished
compared to controls, ∗∗p < 0.01 and ∗p < 0.05, respectively
(Figure 7E). We observed a similar main effect of treatment
in males with one-way ANOVA, F(4,10) = 8.28, p < 0.005,
and similar Tukey’s multiple comparison test results where 10
nM T alone rescued growth inhibition in menadione-treated
cultures compared to controls, but not in the presence of either
letrozole where growth was significantly reduced compared to
controls, ∗∗p< 0.01, or flutamide, ∗p< 0.05 compared to control
(Figure 7F).
Discussion
Adult NSPCs are the principal source of ongoing adult
neurogenesis, providing a mechanism of self-regeneration. Adult
neurogenesis shows a capacity to change in response to altered
levels of sex hormones, a possible basis for sex-dependent adult
neurogenesis. Our present study has utilized neurospheres to
compare equal molar effects of principal sex hormones on male
and female NSPCs.
We demonstrate that T, E2 and P4 can each promote NSPC
proliferation and neurosphere growth. Each sex hormone was
able to enhance neurosphere growth to the same degree at
equal molar concentrations. Of particular note is that all three
sex hormones had the same effect irrespective of genetic sex.
From an in vivo perspective of circulating concentrations, T is
comparatively abundant compared to either E2 or P4 in males,
whilst the opposite is true for premenopausal females. At the
cellular level, in vitro at least, it appears that the genetic sex
of NSPCs does not program proliferative responses to what
are generally considered sex-specific hormones. This is perhaps
not true for the mechanism by which T exerts its effects as
discussed later. The capacity for T, E2 and P4 to promote
NSPC proliferation was dependent on the presence of the potent
mitogens EGF and FGF2. Removal of these factors resulted in a
clearly evident paucity in neurosphere formation. We therefore
suggest that the observed proliferative enhancement exerted by
each sex hormone could be the result of potentiated EGF and
FGF2 signal transduction.
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FIGURE 7 | Neurospheres displayed reduced size when grown in the
presence of 10 µM menadione (A, example show male
neurospheres ± menadione for 5 days). Neurospheres grown for
5 days ± 10 µM menadione were allowed to adhere to a laminin substrate
for 1 h then fluorescently stained with DAPI (blue) and an antibody to nestin
(green) showing that oxidative stress disrupted nestin(+) morphology
(B, example shows male neurospheres). Neurosphere growth over 7 days
was significantly impaired by 10 µM menadione alone compared to
controls but not with concomitant exogenous addition of 10 nM E2 in
females (C) and males (D). However, inhibiting intrinsic E2 synthesis with
letrozole significantly exacerbated the menadione-induced impaired growth
in males (D) but not females (C). An independent set of experiments
showed addition of 10 nM exogenous testosterone could abolish
menadione-impaired neurosphere growth compared to controls, which
was prevented with the co-addition of letrozole but not flutamide in females
(E) and males (F). Results show mean ± SEM, ∗p < 0.05, ∗∗p < 0.01,
∗∗∗p < 0.005, ∗∗∗p < 0.001, one-way ANOVA with Tukey’s multiple
comparisons test.
Receptors for T, E2 and P4 belong to a related family
of intracellular steroid nuclear receptors. ‘‘Classic’’ steroid
hormone signaling describes the translocation of these receptors
in complexes to the nucleus to modifying gene expression
(Guerriero, 2009). This form of signaling is generally considered
on a longer time-scale compared to signal-transduction utilizing
rapid protein phosphorylation events. E2 in particular has been
observed to produce rapid effects in neural tissue such as
synapse modifications (Srivastava et al., 2011) and contributed to
speculation of the existence of transmembrane receptors capable
of transducing rapid signaling through protein phosphorylation.
We suggest this mechanism could partly underlie the enhanced
neurosphere growth we report here. U0126 is an inhibitor of
MEK1-mediated Erk phosphorylation and cell-based assays show
concentrations of 10 µM can suppress Erk phosphorylation and
also abolish Erk phosphorylation stimulated by either EGF or
FGF2 (Davies et al., 2000; Jin et al., 2005; Bain et al., 2007;
Dottori et al., 2008). Using 20 µM U0126, we demonstrated
a loss of the growth-promoting effects of each sex hormone.
Coupled with our demonstration that NSPC-proliferation was
stimulated within 20 min of sex hormone application, we suggest
that T, E2 and P4 could potentiate protein kinase signaling
induced by EGF and FGF2. This notion is strengthened when we
consider independent studies have shown that T can stimulate
Erk phosphorylation (Estrada et al., 2003) and that Mitogen-
activated protein kinase (MAPK) signaling is instrumental
in maintaining NSPC proliferation (Faigle and Song, 2013).
QuantitativeWestern blot analyses could further substantiate the
involvement of MEK1-Erk signaling in response to sex hormone
stimulation, since upstream kinases other than MEK1 could still
target Erk for phosphorylation. Furthermore, our current data
cannot conclusively exclude a contribution at the level of AR
or ER-mediated gene transcription. Transcriptional analyses of
adult NSPCs in response to sex hormones as a function of genetic
sex are ongoing areas of investigation in our laboratory. We have
summarized a possible mechanism in Figure 8.
At a cellular level the liberation of mitochondrial cholesterol
is the initial step in de novo sex hormone synthesis followed by
a series of reactions catalyzed by specific steroidogenic enzymes
(Miller and Auchus, 2011). An outstanding question emanating
from our present study concerns determining whether
adult NSPCs synthesize sex hormones de novo. However,
demonstrating that AR inhibition in female neurospheres
reduced their growth could suggest innate androgen synthesis
participates in basal NSPC proliferation in vitro at least. In
contrast, a reduction in basal male neurosphere growth was
observed only when the AR and aromatase were concomitantly
inhibited. A feature of cells expressing subsets of steroidogenic
enzymes is their capacity to metabolize exogenous sex hormones.
In principal then, the function of aromatase in NSPCs could be
either innate E2 synthesis or exogenous T metabolism into E2.
We observed that exogenous T stimulated female neurosphere
growth when aromatase was inhibited but was dependent on the
AR. This was not the case in male NSPCs where T promoted
neurosphere growth in the presence of AR antagonism, but
not when aromatase activity was inhibited. This presents an
Frontiers in Cellular Neuroscience | www.frontiersin.org 9 July 2015 | Volume 9 | Article 253
Ransome and Boon Adult neurospheres and sex hormone
FIGURE 8 | Schematic diagram depicting EGF, fibroblast growth factor
2 (FGF2) and their respective transmembrane receptors (EGFR and
FGFR) stimulating intracellular protein kinases, including MEK1-Erk,
leading to cellular proliferation. Extracellular T, E2 and P4 freely cross
plasma membranes to bind intracellular cognate AR, ER or PR, respectively.
The neurosphere growth-promoting effects of T, E2 and P4 could be mediated
through potentiating protein kinase signaling stimulated by EGF and FGF2,
where co-application of the MEK1 inhibitor U0126 impairs their respective
potentiation effects. There may also be a contribution through classical steroid
hormone signaling mediated by nuclear translocation of cognate receptors
that interact with hormone response elements with resulting gene
transcription.
important sex-specific aspect to our current study; aromatase
metabolism of T into E2 plays a role in male but not female
NSPC proliferation. This idea is supported by previous studies
reporting higher levels of aromatase in adult male neurospheres
(Waldron et al., 2010b), which accords with our current data
derived from Western blot protein analyses and also our new
GFP-aromatase reporter model. Moreover, male bias for local
aromatase expression reconciles with a ‘‘male need’’ for local E2
synthesis compared to females given the disparity in circulating
E2 levels.
The physiological functions of brain aromatase remain
unknown, however a capacity for local E2 synthesis to enhance
synaptic plasticity and support injured neurons implies a
possible neuroprotective role (Garcia-Segura et al., 2003).
Neuroprotective properties are not fully sufficient to redress
the inevitable neuronal cell death resultant from severe brain
injury. Inducible expression in NSPCs could conceivably afford
aromatase a neuro-restorative role as well. Such a notion
is supported by experimental stroke models showing local
aromatase-mediated E2 synthesis is required for injury (stroke)-
induced neurogenesis (Li et al., 2011). We employed a model
of oxidative stress primarily because this pathology is common
in neurodegenerative diseases, traumatic brain injuries and
stroke (Cornelius et al., 2013). Aromatase expression increased
in neurospheres with raised levels of ROS demonstrating in
principal that trauma or injury could induce innate E2 synthesis
in NSPCs. Although oxidative stress impaired neurosphere
growth in both sexes, concomitant aromatase inhibition
exacerbated the impairment, primarily in male neurospheres.
While induced cellular E2 synthesis alone appeared insufficient
to fully block ROS-mediated growth impairment, aromatase
nonetheless attenuated the impairment. We also examined
relative androgenic and estrogenic actions of exogenous T on
its ability to rescue oxidative stress-impaired neurosphere
growth. Of important note, when T was given alone it could
significantly, though mildly, reverse the ROS-induced reduction
in neurosphere growth in both sexes. However, if aromatase-
mediated metabolism of T into E2 was inhibited then this rescue
effect of exogenous T was lost. The collective oxidative stress
data allude to the notion that androgenic actions of T could
be detrimental under pathological conditions and may explain
why induced aromatase-mediated E2 synthesis was not fully
protective. This idea has been postulated previously, though the
effects of androgens in the pathological brain remain equivocal
(Ransome, 2012a; Quillinan et al., 2014).
A key ability of inducible aromatase expression is to
control the relative androgenic and estrogenic signaling at
the cellular level. Recent clinical data from severe traumatic
brain injury patients assessed the ratio of E2 to T levels in
the cerebrospinal fluid (CSF) in relation to patient outcomes.
This study provided two key points, firstly it measured sex
hormones in the CNS environment (i.e., CSF) rather than
circulating levels to show high E2 to T ratio was associated
with better outcomes compared to a low ratio. Secondly, it
showed a co-association of this effect with polymorphisms in
the aromatase gene. Moreover, we suggest that aromatase could
play both a role in neuroprotection and neuro-restoration by
supporting NSPCs under pathological conditions. Our current
study focused primarily on examining neurosphere growth
through NSPC proliferation, which plays an essential role in
expanding neural progenitor cells in the normal and pathological
environment. Another question that waits empirical testing is
whether aromatase supports neural differentiation and survival
under pathological conditions. We are currently exploring
this hypothesis and whether pharmacological promotion of
estrogenic signaling at the expense of androgenic signaling is an
efficacious strategy to replace the inevitable death of neurons in
acquired brain injuries.
Concluding Remarks
We used isolated adult NSPCs to demonstrate a direct response
to principal sex hormones irrespective of genetic sex. However,
while T acts substantively through the AR in female NSPCs,
male response to T could be elicited by either AR or ER as
a consequence of higher aromatase expression. Given that T
is synonymous with male sexual differentiation, a male bias
in the aromatase-mediated E2 synthesis is counter intuitive.
However, this notion is reconciled if we propose that E2 plays
fundamental non-reproductive roles in both sexes. Hence the
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male profile of comparatively low circulating E2 but high T
would be consistent with higher levels of localized aromatase
expression. We additionally provide evidence that aromatase-
mediated E2 synthesis could support the innate NSPCs response
in brain injuries. Our future studies will aim to trace aromatase
expression in differentiating progeny of adult NSPCs to examine
ways of supporting neuronal production under pathological
conditions.
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